|
|
Profusa To Offer 5,102,040 Shares At $2.94/Share
|
|
|
|
Profusa To Collaborate With Mayo Clinic On New Investigation Of Profusa Tech For Clinical Applications
|
|
|
|
Profusa Partners With Mayo Clinic Over Clinical Applications Of Profusa's Oxygen Monitoring Technologies To Develop, Commercialize New Products
|
|
|
|
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
|
|
|
|
Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
|
|
|
|
Profusa shares are trading lower after the company announced a 1-for-75 reverse stock split.
|
|
|
|
Profusa Announces 1-For-75 Reverse Stock Split, Effective Feb. 9
|
|
|
|
Profusa Presents Trial Results From Pilot Phase Study Of Peripheral Artery Disease Participants With Subcutaneous Hydrogel Sensors Implanted In The Arm And Foot
|
|
|
|
12 Health Care Stocks Moving In Friday's After-Market Session
|
|
|
|
Profusa Stock Spikes As Lumee System Targets Research Market
|
|